Pharmacokinetic evaluation of continuous intravenous epoprostenol

By Chaumais Marie-Camille   Jobard Marion   Huertas Alice   Vignand-Courtin Claire   Humbert Marc   Sitbon Olivier   Rieutord André   Montani David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1587-1598

Informa Healthcare

Access to resources Recommend Favorite

Epoprostenol: Pulmonary oedema: case report

By  

Reactions Weekly, Vol. 1, Iss. 1342, 2011-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Eisenmenger syndrome: medical prevention and management strategies

By Budts Werner  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2047-2060

Informa Healthcare

Access to resources Recommend Favorite

Combined treatment with epoprostenol and anticoagulants may be associated with an increased risk of pulmonary haemorrhage

By  

Reactions Weekly, Vol. 1, Iss. 1043, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Epoprostenol: Micrococcal bacteraemia in patients with pulmonary hypertension: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1222, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite